Sandoz Canada Joins Humira Biosimilar Race With Hyrimoz Approval

Enoxaparin Biosimilar Inclunox Also Approved By Health Canada

 
• By Dean Rudge
  
Canadian flag waving_567680776_1200
Sandoz Canada is looking to launch both adalimumab and enoxaparin early in 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin